Free regulatory intelligence — powered by Certivo
Public CommentProposedProposed RegulationPublic CommentSubstance Addition

Illinois HB0077 proposed to add xylazine to Schedule III and create exemptions for veterinary and related lawful uses (last action Mar 21, 2025)

Illinois Controlled Substances Act (720 ILCS 570)Illinois General AssemblyUS, Illinois
Announced

Mar 21, 2025

Description

HB0077 (104th General Assembly) proposes amending the Illinois Controlled Substances Act to schedule xylazine as a Schedule III controlled substance and to establish explicit exemptions for defined lawful activities (e.g., use by licensed veterinarians in professional practice; certain euthanasia technicians; wildlife biologists under veterinary supervision; other specified lawful uses). The bill status page shows last action on 2025-03-21 (re-referred to Rules Committee). If enacted, regulated entities (veterinary practices, suppliers, facilities handling xylazine) would need to implement controlled-substance handling controls unless covered by an exemption.

Get compliance alerts for Illinois Controlled Substances Act (720 ILCS 570)

Certivo tracks regulatory changes and automates compliance workflows for your products.

Start Free Trial